Investor Overview

BetterLife is an emerging biotech company creating and clinically validating 2nd-Generation Non-Hallucinogenic Psychedelic compounds and drug delivery mechanisms for clinical trials and commercialization of cutting-edge treatments for mental disorders.

Corporate Summary

As an emerging biotech company, focused on the development and commercialization of cutting-edge treatments for the universal unmet mental health conditions, we are led by an accomplished global team of researchers, scientists, experts, and management.

Based out of Vancouver, Canada, we have developed strategic relationships across Canada, United States and Switzerland to develop, advance, and deliver on patient-friendly medicines that will help reduce the mental health footprint.

Our Market Differentiation

Meaning  comes from execution plus adoption of concept-to-delivery solutions to gain traction with transparency, dependability, and authority leading to a widespread adoption for the unmet needs.

Our Uniqueness

… resides in our Patient-Friendly solutions that will help us create sustainable long-term value for patients, shareholders, and stakeholders.

BetterLife Pharma’s Patient-Friendly approach is bringing the most amount of good to the greatest number of people in the most efficient way! This is based on four key principles.

Patient - Friendly

Accessible

In Home Treatment

Affordable

Not Cost Prohibitive

Applicable

Patent Protected

Allowable

Not Scheduled/Regulated

Media & Events

All
Media

Investor Mailing List

Contact Us
Working together to Build a BetterLife for all.

INVESTOR OVERVIEW

BetterLife Investor Presentation

Working to Build a BetterLife, with innovate medicines.

 

Our work delivers patient-friendly medicines to rejuvenate and restore the health of the mind and the body.

 
Email us: ir@blifepharma.com
 

Follow us: